4//SEC Filing
Shea Jacqueline Elizabeth 4
Accession 0001055726-25-000020
CIK 0001055726other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:39 PM ET
Size
9.1 KB
Accession
0001055726-25-000020
Insider Transaction Report
Form 4
Shea Jacqueline Elizabeth
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-05-10−5,500→ 0 total→ Common Stock (5,500 underlying) - Tax Payment
Common Stock
2025-05-10$1.80/sh−2,392$4,306→ 49,658 total - Exercise/Conversion
Common Stock
2025-05-10+5,500→ 52,050 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units was as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares vested on May 10, 2025. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001771498
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:39 PM ET
- Size
- 9.1 KB